ClinConnect ClinConnect Logo
Search / Trial NCT06406959

The Effect of Preemptive Regional Anesthesia (TAP-block) on Acute and Chronic Pain After Transabdominal Preperitoneal Inguinal Hernia Repair (TAPP)

Launched by PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY · May 7, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Transverse Abdominis Plane Block Inguinal Hernia Tapp Technique Chronic Postoperative Pain Acute Pain Inguinal Hernia Surgery

ClinConnect Summary

This clinical trial is studying how a specific type of anesthesia, called a Transversus Abdominal Plane (TAP) block, can help reduce pain after surgery for a condition known as a primary inguinal hernia. The surgery being examined is called Transabdominal Preperitoneal (TAPP) hernia repair, which is a common and minimally invasive procedure. The goal is to see if using this anesthesia technique beforehand can help patients experience less pain both right after the surgery and in the weeks or months that follow.

To be eligible for this study, participants must be adults aged 65 to 74 who are scheduled for this type of hernia repair and meet certain health criteria, including having a body mass index (BMI) of 35 or less. People with specific types of hernias, certain mental health conditions, or who take certain medications may not qualify. If you decide to participate, you will receive the TAP block before your surgery, and researchers will monitor your pain levels after the procedure. This trial is currently recruiting participants, and it's an opportunity to contribute to improving pain management for future patients undergoing similar surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with unilateral primary inguinal hernia who are scheduled for elective Transabdominal preperitoneal inguinal hernia repair (TAPP)
  • Signed Informed consent to participation
  • ASA I-III
  • BMI ≤35 kg/m2
  • Non-inclusion Criteria:
  • Inguinoscrotal hernia (hernia passing through the entrance to the scrotum)
  • Previously diagnosed mental disorders
  • Patients receiving psychotropic drugs and drugs affecting adrenal cortex function (estrogens and systemic glucocorticoids)
  • Language barrier
  • Exclusion Criteria:
  • Deviations during the operation/anesthesia that required transfer to the intensive care unit or conversion to open surgery
  • Refusal to participate

About Pirogov Russian National Research Medical University

Pirogov Russian National Research Medical University is a prestigious academic institution dedicated to advancing medical science and education in Russia. Renowned for its commitment to high-quality research and innovation, the university plays a pivotal role in clinical trials aimed at improving healthcare outcomes. With a multidisciplinary approach, it fosters collaboration among leading experts in various medical fields, ensuring the development of safe and effective therapeutic interventions. The institution is focused on translating research findings into clinical practice, thereby contributing significantly to the advancement of medical knowledge and patient care both nationally and internationally.

Locations

Moscow, , Russian Federation

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported